Antibody Therapeutics for Life

Notices

PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited to present at the 73rd Annual Conference of KAOBS.
  • Written by Admin
  • Written date 2019-01-14 11:37:45
  • Inquire 1798

PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine 

is invited to present at the 73rd Annual Conference of KAOBS: Korean Association of Biological Sciences 

(http://www.kaobs.or.kr/international/default.asp) on August 22-24, 2018.

List





Prev PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. ...
Next PharmAbcine, a clinical stage immuno-oncology company announced that PharmAbcine...